"Pharmaceutical Representative Licensing Act."

This bill requires pharmaceutical representatives in New Jersey to obtain a state license before promoting drugs to healthcare practitioners. It establishes the State Board of Medical Examiners to oversee licensing, set standards, and enforce rules. Key requirements include: completing a professional education course, paying fees, undergoing biennial renewal with six hours of continuing education (covering ethics, pharmacology, opioid alternatives, and marketing laws), and submitting detailed reports every two years about all interactions with practitioners (including drugs promoted, samples/gifts given, and payments made). The bill also prohibits deceptive marketing, misleading titles, and attending patient exams without consent, with licenses subject to suspension or revocation for violations.